Who
Deborah L. Keller
Director
Company insider
Files Form 4 as: Director, West Pharmaceutical Services; CEO, Covance Drug Development, Labcorp Holdings; Corp. Executive Vice President, Covance.
In numbers
- Trades disclosed
- 102
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $5.9M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 22 Feb 2007
- Last trade
- 4 May 2026
- Last filed
- 6 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 6 May 2025filed 8 May 2025 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,071 at $0.00 | filing |
| 23 Apr 2024filed 25 Apr 2024 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —564 at $0.00 | filing |
| 25 Apr 2023filed 27 Apr 2023 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —616 | filing |
| 24 May 2022filed 26 May 2022 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —632 | filing |
| 4 May 2021filed 6 May 2021 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —577 | filing |
| 5 May 2020filed 7 May 2020 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —975 | filing |
| 7 May 2019filed 9 May 2019 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,565 | filing |
| 31 Dec 2018filed 3 Jan 2019 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K204 at $98.03 | filing |
| 28 Sep 2018filed 2 Oct 2018 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K162 at $123.74 | filing |
| 29 Jun 2018filed 1 Aug 2018 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K202.14 at $99.29 | filing |
| 1 May 2018filed 3 May 2018 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,824 at $0.00 | filing |
| 29 Mar 2018filed 1 Aug 2018 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K227.67 at $86.72 | filing |
| 29 Dec 2017filed 1 Aug 2018 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K202.08 at $99.16 | filing |
| 29 Sep 2017filed 3 Oct 2017 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $20K207.62 at $96.33 | filing |
| 30 Jun 2017filed 5 Jul 2017 | WST West Pharmaceutical Servicesoption or derivative · Medical Devices | SEC FORM 4 Code A | $6,66770.63 at $94.39 | filing |
| 1 Jun 2017filed 2 Jun 2017 | WST West Pharmaceutical ServicesMedical Devices | SEC FORM 4 Code A | —1,483 at $0.00 | filing |
| 11 Mar 2016filed 15 Mar 2016 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —1,220 | filing |
| 11 Mar 2016filed 15 Mar 2016 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $43K374 at $115.49 | filing |
News
No headline names them, or the companies they trade most, lately.